In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Chattem forecast

This article was originally published in The Rose Sheet

Executive Summary

Firm raises its FY 2007 earnings-per-share guidance to $2.94 to $3.19; the adjustment anticipates sales growth from the five brands acquired from Johnson & Johnson in January. "We're still launching these new products, and small moves in sales can result in big moves in profitability," President and COO Robert Bosworth said at the SunTrust Robinson Humphrey Institutional Conference April 10. Advertising for the new brands, which began in February, is showing "strong responses," the exec said. Shipping and distribution of the brands were assimilated into the firm in April. For the remainder of FY 2007 and into FY 2008, new products and packaging will be introduced, and the manufacturing of lotions, creams and ointments will be brought in-house, Bosworth said...



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts